Information about in vitro diagnostics included in News is intended for disclosure of corporate information. It is not intended to promote or advertise in vitro diagnostics.
Year
- Nov 14, 2025 News Release Notice of Revision of Dividend Forecast
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Jan 22, 2025 News Release (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
- Nov 14, 2025 News Release Notice of Revision of Dividend Forecast
- Jul 14, 2025 News Release Notice Regarding Withdrawal of Application for Change of Market Classification
- Jun 26, 2025 News Release Notice regarding Selection of Our Company’s Shares as Loan Margin Trading Issue
- May 09, 2025 News Release (Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
- Apr 28, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests for Early Cancer Detection.
- Apr 04, 2025 News Release Notice of Capital and Business Alliance with Aillis, Inc.and Acquisition of Shares through Third-Party Allocation of New Shares.
- Apr 01, 2025 News Release TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes.
- Feb 06, 2025 News Release Notice of Strategic Business Alliance with ZACROS Corporation
- Jan 28, 2025 News Release Patent on Method and Reagent for Detecting Target Substance Granted in Japan
- Jan 22, 2025 News Release (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
- No posts
